Compare Stocks → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CNSX:BLOOTCMKTS:CHEOFOTCMKTS:CHEOYOTCMKTS:VYCO Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLOCannabix TechnologiesC$0.00C$0.40▼C$2.95N/AN/A301,179 shs188,592 shsCHEOFCochlear$204.04$219.28$145.73▼$230.46N/AN/A164 shsN/ACHEOYCochlear$102.65-0.8%$108.57$73.73▼$114.50$13.55B0.913,859 shs3,159 shsVYCOVycor Medical$0.08$0.09$0.04▼$0.10N/AN/A14,221 shsN/A7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLOCannabix Technologies0.00%0.00%0.00%0.00%0.00%CHEOFCochlear0.00%-2.37%-8.07%+0.04%+25.02%CHEOYCochlear-0.68%+0.68%-6.25%+3.63%+24.12%VYCOVycor Medical0.00%0.00%-4.76%+1.82%-9.85%“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLOCannabix TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/AN/AN/AN/AN/ACHEOYCochlearN/AN/AN/AN/AN/AN/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLOCannabix TechnologiesN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/ACHEOYCochlear1.50ReduceN/AN/AVYCOVycor MedicalN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLOCannabix TechnologiesN/AN/AN/AN/AN/AN/ACHEOFCochlearN/AN/AN/AN/AN/AN/ACHEOYCochlear$1.32B10.21N/AN/AN/A∞VYCOVycor MedicalN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLOCannabix TechnologiesN/AN/A0.00N/AN/AN/AN/AN/AN/ACHEOFCochlearN/A$1.64124.26∞N/AN/AN/AN/AN/ACHEOYCochlearN/AN/A0.0044.83N/AN/AN/AN/AN/AVYCOVycor MedicalN/A-$0.43N/A∞N/AN/AN/AN/A5/12/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLOCannabix TechnologiesN/AN/AN/AN/AN/ACHEOFCochlear$1.270.62%N/A77.34%N/ACHEOYCochlear$1.161.13%N/AN/AN/AVYCOVycor MedicalN/AN/AN/AN/AN/ALatest VYCO, BLO, CHEOF, and CHEOY DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/16/2024CHEOYCochlear$0.03361%3/21/20243/22/20244/30/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLOCannabix TechnologiesN/ACHEOFCochlear22.47%CHEOYCochlearN/AVYCOVycor Medical40.26%Insider OwnershipCompanyInsider OwnershipBLOCannabix TechnologiesN/ACHEOFCochlearN/ACHEOYCochlearN/AVYCOVycor MedicalN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBLOCannabix TechnologiesN/AN/AN/ANot OptionableCHEOFCochlear4,800N/AN/ANot OptionableCHEOYCochlear4,800130.99 millionN/ANot OptionableVYCOVycor Medical6N/AN/ANot OptionableVYCO, BLO, CHEOF, and CHEOY HeadlinesSourceHeadlineBlueChew Review 2024medicalnewstoday.com - January 17 at 6:44 PMWhat to know about bleeding hemorrhoidsmedicalnewstoday.com - December 19 at 8:43 AMCommon symptoms of depression: What to knowmedicalnewstoday.com - October 11 at 10:44 PMVycor Medical, Inc. (VYCO)finance.yahoo.com - January 7 at 6:28 PMMedical Review Boardhealth.usnews.com - November 1 at 6:14 PMMedical Scholars Programslu.edu - September 12 at 10:45 AMVycor Medical Increuters.com - September 8 at 10:15 AMMinnetronix commercializes its own product: a minimally invasive deep brain access portmedcitynews.com - August 20 at 1:18 AMViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsnice.org.uk - May 12 at 12:34 AMVycor Medical Year to Date Total Returns (Daily)ycharts.com - January 2 at 10:20 AMVycor Medical Inc (VYCO)nasdaq.com - December 17 at 11:51 PMThe journal of physical chemistry. Bmedscape.com - October 18 at 10:40 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioStock market today: Global benchmarks mostly climb despite worries about US economyApril 26, 2024 3:21 AMView Stock market today: Global benchmarks mostly climb despite worries about US economyFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentCaterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesApril 25, 2024 10:36 AMView Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesPayPal’s User Decline Won’t Stop Its Double-Digit UpsideApril 16, 2024 9:08 AMView PayPal’s User Decline Won’t Stop Its Double-Digit UpsideAll Headlines Company DescriptionsCannabix TechnologiesCNSX:BLOCannabix Technologies Inc., a technology company, develops marijuana breathalyzer for law enforcement and the work place in North America. It develops drug-testing devices that will detect tetrahydrocannabinol using breath samples at roadside and identify drivers under the influence of marijuana. The company was formerly known as West Point Resources Inc. and changed its name to Cannabix Technologies Inc. in August 2014. Cannabix Technologies Inc. was incorporated in 2011 and is based in Burnaby, Canada.CochlearOTCMKTS:CHEOFCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.CochlearOTCMKTS:CHEOYCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Vycor MedicalOTCMKTS:VYCOVycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.